WGS
GeneDx Holdings Corp. (WGS) reported net income of -$21.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$21.00M | +59.8% |
| FY 2024 | -$52.30M | +70.3% |
| FY 2023 | -$175.80M | +68.0% |
| FY 2022 | -$548.98M | -123.7% |
| FY 2021 | -$245.39M | -1.7% |
| FY 2020 | -$241.34M | -712.5% |
| FY 2019 | -$29.70M | - |
GeneDx Holdings Corp. (WGS) reported net income of -$21.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, GeneDx Holdings Corp.'s net income grew from -$29.70M to -$21.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.